GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CHC Healthcare Group (TPE:4164) » Definitions » EV-to-EBIT

CHC Healthcare Group (TPE:4164) EV-to-EBIT : 21.51 (As of Jun. 08, 2024)


View and export this data going back to 2012. Start your Free Trial

What is CHC Healthcare Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CHC Healthcare Group's Enterprise Value is NT$11,934 Mil. CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$555 Mil. Therefore, CHC Healthcare Group's EV-to-EBIT for today is 21.51.

The historical rank and industry rank for CHC Healthcare Group's EV-to-EBIT or its related term are showing as below:

TPE:4164' s EV-to-EBIT Range Over the Past 10 Years
Min: -478.42   Med: 22.86   Max: 170.5
Current: 21.51

During the past 13 years, the highest EV-to-EBIT of CHC Healthcare Group was 170.50. The lowest was -478.42. And the median was 22.86.

TPE:4164's EV-to-EBIT is ranked worse than
68.29% of 82 companies
in the Medical Distribution industry
Industry Median: 13.855 vs TPE:4164: 21.51

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CHC Healthcare Group's Enterprise Value for the quarter that ended in Mar. 2024 was NT$13,610 Mil. CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$555 Mil. CHC Healthcare Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.08%.


CHC Healthcare Group EV-to-EBIT Historical Data

The historical data trend for CHC Healthcare Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHC Healthcare Group EV-to-EBIT Chart

CHC Healthcare Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.16 16.31 17.01 19.12 21.08

CHC Healthcare Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.98 27.23 28.19 21.08 24.53

Competitive Comparison of CHC Healthcare Group's EV-to-EBIT

For the Medical Distribution subindustry, CHC Healthcare Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHC Healthcare Group's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CHC Healthcare Group's EV-to-EBIT falls into.



CHC Healthcare Group EV-to-EBIT Calculation

CHC Healthcare Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=11933.519/554.715
=21.51

CHC Healthcare Group's current Enterprise Value is NT$11,934 Mil.
CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$555 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group  (TPE:4164) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CHC Healthcare Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=554.715/13609.5687
=4.08 %

CHC Healthcare Group's Enterprise Value for the quarter that ended in Mar. 2024 was NT$13,610 Mil.
CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$555 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CHC Healthcare Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CHC Healthcare Group (TPE:4164) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.

CHC Healthcare Group (TPE:4164) Headlines

No Headlines